ATARA BIOTHERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Other Comprehensive Income (Loss), Net of Tax of $117.00 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2015-11-06
- ATARA BIOTHERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2015-09-30 was $117.00K.
- ATARA BIOTHERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2015-06-30 was -$48.00K, a 536.36% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2015-03-31 was $82.00K.
- ATARA BIOTHERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2014-12-31 was -$89.00K.
- ATARA BIOTHERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2014 was -$100.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2015-09-30 | $117.00K 10-Q · filed 2015-11-06 | $69.00K derived: sum of 2 quarters · filed 2015-11-06 | $151.00K 10-Q · filed 2015-11-06 | $62.00K derived: sum of 4 quarters · filed 2015-11-06 |
| 2015-06-30 | -$48.00K 10-Q · filed 2015-08-07 | $34.00K 10-Q · filed 2015-08-07 | -$55.00K derived: sum of 3 quarters · filed 2015-08-07 | -$66.00K derived: sum of 4 quarters · filed 2015-11-06 |
| 2015-03-31 | $82.00K 10-Q · filed 2015-05-11 | -$7.00K derived: sum of 2 quarters · filed 2015-05-11 | -$18.00K derived: sum of 3 quarters · filed 2015-11-06 | -$7.00K derived: sum of 4 quarters · filed 2015-11-06 |
| 2014-12-31 | -$89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$100.00K derived: sum of 2 quarters · filed 2015-11-06 | -$89.00K derived: sum of 3 quarters · filed 2015-11-06 | -$100.00K 10-K · filed 2015-02-26 |
| 2014-09-30 | -$11.00K 10-Q · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | -$11.00K 10-Q · filed 2015-11-06 | |
| 2014-06-30 | $11.00K 10-Q · filed 2015-08-07 | $0.00 derived: sum of 2 quarters · filed 2015-08-07 | ||
| 2014-03-31 | -$11.00K 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |